[Prognosis for the infant in pyelonephritis during pregnancy].
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001724:Birth Weight; D002908:Chronic Disease; D005260:Female; D005865:Gestational Age; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced; D007226:Infant Mortality; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis*; D007234:Infant, Premature; D009582:Nitrofurantoin / Q000009:adverse effects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000453:epidemiology; D011295:Prenatal Care; D011379:Prognosis; D011704:Pyelonephritis / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D009582:Nitrofurantoin
Prognose des Kindes bei Pyelonephritis gravidarum.